{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Armata Pharmaceuticals, Inc.
Is Armata Pharmaceuticals, Inc. technically bullish or bearish?
As of October 1, 2023, there is insufficient technical data for Armata Pharmaceuticals, Inc. to determine a bullish or bearish outlook.
Who are in the management team of Armata Pharmaceuticals, Inc.?
As of March 2022, the management team of Armata Pharmaceuticals, Inc. includes Mr. Richard Bastiani (Independent Chairman), Mr. Todd Patrick (CEO and Director), Ms. Robin Kramer (Director), and Independent Directors Dr. Odysseas Kostas, Mr. Joseph Patti, and Dr. Todd Peterson. They oversee the company's strategic direction and operations.
What does Armata Pharmaceuticals, Inc. do?
Armata Pharmaceuticals, Inc. is a biotechnology company specializing in phage therapeutics. As of March 2025, it has a market cap of $67.32 million, with net sales of $0 million and a net loss of $7 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
